PTH and hypercalcemia disease: A study by Seong Hoon Kim et al. outlined PTX indications in sHPT as medical therapy resistance, symptomatic disease, and persistently elevated PTH, whereas in tHPT, indications include persistent hypercalcemia, nephrolithiasis, and declining kidney graft function [26].